Search research articles
Contact Us
Filters
Showing results (101-110 of 123) with videos related to
Page
of 13
Sort By:
Archives of Gynecology and Obstetrics
|
June 29, 2021
Lymphovascular space invasion as a prognostic factor of epithelial ovarian cancer: a multicenter study by the FRANCOGYN group
Jerome Lorenzini, Julien Cirier, Gilles Body, et al.
Journal of Clinical Medicine
|
April 3, 2021
Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group
Grégoire Rocher, Thomas Gaillard, Catherine Uzan, et al.
Annals of Surgical Oncology
|
April 27, 2021
Status of Surgical Management of Borderline Ovarian Tumors in France: are Recommendations Being Followed? Multicentric French Study by the FRANCOGYN Group
Lise Lecointre, Virginie Bund, Eva Sangnier, et al.
Annals of Surgical Oncology
|
April 14, 2024
The Influence of Surgical Complexity and Center Experience on Postoperative Morbidity After Minimally Invasive Surgery in Gynecologic Oncology: Lessons Learned from the ROBOGYN-1004 Trial
Eric Lambaudie, Emilie Bogart, Marie-Cécile Le Deley, et al.
Journal of Gynecology Obstetrics and Human Reproduction
|
July 5, 2021
Lymphovascular invasion as a criterion for adjuvant chemotherapy for FIGO stage I-IIa clear cell carcinoma, mucinous, low grade serous and low grade endometrioid ovarian cancer
Julie Delvallée, Mathilde Cancel, Gilles Body, et al.
Journal of Clinical Medicine
|
November 4, 2020
Impact on Prognosis of the Surgical Route, Laparoscopy or Laparotomy, for the Surgical Staging of Early Stage Ovarian Cancer-A Study from the FRANCOGYN Group
Margaux Merlier, Yohan Kerbage, Adeline Pierache, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 5, 2021
Adherence to European ovarian cancer guidelines and impact on survival: a French multicenter study (FRANCOGYN)
Floriane Jochum, Tamara De Rozario, Lise Lecointre, et al.
Journal of Gynecology Obstetrics and Human Reproduction
|
April 25, 2020
Prognostic value of posttreatment FEDG-PET imaging following combined chemoradiation therapy in locally advanced cervical cancer
Sophie Knight, Julien Mancini, Cyril Touboul, et al.
Journal of Clinical Medicine
|
August 6, 2020
Impact of Lymphadenectomy on Survival of Patients with Serous Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: A French National Multicenter Study (FRANCOGYN)
Virginie Bund, Lise Lecointre, Michel Velten, et al.
Gynecologic Oncology
|
May 30, 2020
Severe perioperative morbidity after robot-assisted versus conventional laparoscopy in gynecologic oncology: Results of the randomized ROBOGYN-1004 trial
Fabrice Narducci, Emilie Bogart, Thomas Hebert, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 123) with videos related to
Sort By:
Page
of 13
Archives of Gynecology and Obstetrics
|
June 29, 2021
Lymphovascular space invasion as a prognostic factor of epithelial ovarian cancer: a multicenter study by the FRANCOGYN group
Jerome Lorenzini, Julien Cirier, Gilles Body, et al.
Journal of Clinical Medicine
|
April 3, 2021
Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group
Grégoire Rocher, Thomas Gaillard, Catherine Uzan, et al.
Annals of Surgical Oncology
|
April 27, 2021
Status of Surgical Management of Borderline Ovarian Tumors in France: are Recommendations Being Followed? Multicentric French Study by the FRANCOGYN Group
Lise Lecointre, Virginie Bund, Eva Sangnier, et al.
Annals of Surgical Oncology
|
April 14, 2024
The Influence of Surgical Complexity and Center Experience on Postoperative Morbidity After Minimally Invasive Surgery in Gynecologic Oncology: Lessons Learned from the ROBOGYN-1004 Trial
Eric Lambaudie, Emilie Bogart, Marie-Cécile Le Deley, et al.
Journal of Gynecology Obstetrics and Human Reproduction
|
July 5, 2021
Lymphovascular invasion as a criterion for adjuvant chemotherapy for FIGO stage I-IIa clear cell carcinoma, mucinous, low grade serous and low grade endometrioid ovarian cancer
Julie Delvallée, Mathilde Cancel, Gilles Body, et al.
Journal of Clinical Medicine
|
November 4, 2020
Impact on Prognosis of the Surgical Route, Laparoscopy or Laparotomy, for the Surgical Staging of Early Stage Ovarian Cancer-A Study from the FRANCOGYN Group
Margaux Merlier, Yohan Kerbage, Adeline Pierache, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 5, 2021
Adherence to European ovarian cancer guidelines and impact on survival: a French multicenter study (FRANCOGYN)
Floriane Jochum, Tamara De Rozario, Lise Lecointre, et al.
Journal of Gynecology Obstetrics and Human Reproduction
|
April 25, 2020
Prognostic value of posttreatment FEDG-PET imaging following combined chemoradiation therapy in locally advanced cervical cancer
Sophie Knight, Julien Mancini, Cyril Touboul, et al.
Journal of Clinical Medicine
|
August 6, 2020
Impact of Lymphadenectomy on Survival of Patients with Serous Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: A French National Multicenter Study (FRANCOGYN)
Virginie Bund, Lise Lecointre, Michel Velten, et al.
Gynecologic Oncology
|
May 30, 2020
Severe perioperative morbidity after robot-assisted versus conventional laparoscopy in gynecologic oncology: Results of the randomized ROBOGYN-1004 trial
Fabrice Narducci, Emilie Bogart, Thomas Hebert, et al.
Page
of 13